AHF Applauds Novel Gonorrhea Treatment
AIDS Healthcare Foundation (AHF) applauds promising clinical trial results for a new drug zoliflodacin, which was co-developed by Swiss nonprofit Global Antibiotic Research & Development Partnership and U.S.-based company Innoviva Specialty Therapeutics to treat gonorrhea.
- AIDS Healthcare Foundation (AHF) applauds promising clinical trial results for a new drug zoliflodacin, which was co-developed by Swiss nonprofit Global Antibiotic Research & Development Partnership and U.S.-based company Innoviva Specialty Therapeutics to treat gonorrhea.
- View the full release here: https://www.businesswire.com/news/home/20231103082562/en/
The "Gonorrhea Alert" billboards, part of an ongoing outdoor advertisement campaign launched by AHF in the U.S., urges the public to visit the www.FreeSTDCheck.org website to learn more about the disease and find locations to access free testing and affordable care in the U.S. for the treatment of sexually transmitted infections. - It’s good to see a nonprofit taking the lead in developing a treatment in a space that has not seen significant innovation in many years,” said AHF President Michael Weinstein.
- Among them is a series of billboards under the theme “ Gonorrhea Alert .”